Indivior Pharmaceuticals, Inc. (INDV)
Healthcare
Drug Manufacturers - Specialty & Generic
37.40 $
-6.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Indivior Pharmaceuticals, Inc. (INDV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -27 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 373 | 310 | 289 | 151 | -193 | 353 | -4.0 | -300 | 36 | -27 | |
| 13 | 14 | 15 | 28 | 26 | 22 | 16 | 15 | 29 | 20 | |
| – | – | – | 3.0 | 8.0 | 11 | 16 | 21 | 24 | 26 | |
| – | – | – | 68 | -52 | -47 | -97 | – | – | – | |
| 310 | 148 | 28 | -79 | -19 | 173 | 118 | -294 | -41 | -257 | |
| 32 | 45 | 39 | 7.0 | 4.0 | 34 | 5.0 | 53 | 29 | 66 | |
| -32 | -45 | -3.8 | -2.0 | -4.0 | -14 | -222 | -95 | 69 | -66 | |
| 63 | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0 | -101 | -90 | -33 | -173 | -11 | |
| – | – | – | -13 | -11 | 6.0 | -12 | -12 | 92 | -17 | |
| -135 | -88 | -226 | -13 | -10 | -94 | -101 | -64 | -102 | -30 | |
| 206 | 171 | 61 | 136 | -202 | 244 | -328 | -458 | 3.0 | -124 | |
| 341 | 265 | 250 | 144 | -197 | 319 | -9.0 | -353 | 7.0 | -93 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.